Conférences  >  Médecine & Soins de Santé  >  Législation en médecine et pharmacologie  >  Virtuel (en ligne)

ComplianceOnline

This 3 hour webinar is focused on understanding the Medical Device Single Audit Program, the scope of the program, how to apply, the Authorized Organizations, the rating system developed and what you can expect when signing onto the program. The webinar will discuss how such audits are organized, what to expect during a MDSAP audit, how does this differ from a typical certified body audit, along with document movement and timeline expectations in receiving the facility’s certificate.

Event Manager;     Tél.: [+1-888-717-2436];     Email.: sshastry@complianceonline.com

The Medical Device Single Audit Program (MDSAP), global medical device regulations seminar, medical device single audit program mdsap, GMP audit, mdsap audit, device classification, licensing pathways, medical device gmp, device labeling, medical device single audit program, medical device single audit program mdsap, fda medical device single audit program, medical device single audit program canada

ComplianceOnline

The program will explain how to determine the needed elements of a quality management system, how to decide which procedures are necessary, and how to configure the system for future growth. The program will also cover the FDA inspection process, and introduce participants to key FDA documents that explain the process in detail and facilitate effective preparation and management of FDA inspections.

Event Manager;     Tél.: [+1-888-717-2436];     Email.: sshastry@complianceonline.com

Introduction to FDA law, regulation and GXP Concepts, Fundamentals of Good Manufacturing Practice, Data Integrity: What it is and why it is important to GMP, Building a GXP Quality Management System, Selection qualification and monitoring of contractors, Phase appropriate GMP considerations – investigational drugs vs commercial, Preparing for and Managing FDA Inspections, Enforcement considerations

ComplianceOnline

This seminar will help all personnel responsible for CMO oversight understand how to ensure effective quality oversight of CMOs- from start to finish. In-depth focus will be placed on Selection and Qualification, CMO Audits, Quality Agreements, Oversight of CMO Operations, and Review of Key CMO Records. Considerations for different types of manufacturing will be highlighted, and techniques for managing difficult CMO situations will be addressed. Techniques for assuring robust CMO Oversight programs in light of COVID-19 restrictions will also be discussed.

Event Manager;     Tél.: [+1-888-717-2436];     Email.: sshastry@complianceonline.com

pharmaceutical contract laboratories, pharmaceutical contract manufacturers in usa, contract drug manufacturers, pharmaceutical contract companies, contract drug manufacturing companies, pharma contract manufacturers, pharmaceutical contract manufacturing companies, outsourcing in pharmaceutical industry, american pharmaceutical outsourcing, pharmaceutical manufacturing industry, pharmaceutical outsourcing trends, pharmaceutical outsourcing companies, pharmaceutical manufacturing process, pharmaceutical contract manufacturing services, CMO Oversight in Pharma Industry, CMO compliance, CMO business model, CMO Qualification Audit, CMO operations, CMO records, CMO situations, CMO audits